Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Microsoft's new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Microsoft's BioEmu, an AI-driven model, decodes protein motion to enhance drug discovery, offering rapid insights into ...

Microsoft's CEO, Satya Nadella, has introduced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding protein motion.

Microsoft’s artificial intelligence tool BioEmu can predict the multiple conformational states of a protein, giving insight into how a protein moves and its potential function.

New API and SDK will enable enterprises to embed research automation into business workflows, enhancing decision-making with ...

Syensqo and Microsoft have signed a Memorandum of Understanding (MOU) to explore a strategic collaboration aimed at accelerating digital innovation and sustainable materials development ...

Microsoft unveiled a new initiative Wednesday that's intended to bring artificial intelligence skills to millions of people ...